The European Patent Office (EPO) has published patent application EP4117582A1 concerning a prosthetic device for aortic valve implantation. This publication, dated March 11, 2026, details the technical specifications of the device, listing NVT AG as the applicant and Maximilian Kuetting and Steffen Westermann as inventors. The application falls under IPC classification A61F 2/24.

This is a patent publication, not a regulatory rule or guidance. It does not impose new compliance obligations or deadlines on regulated entities. Companies involved in the development or manufacturing of medical devices, particularly cardiovascular prosthetics, may find this patent application of interest for competitive intelligence or potential licensing opportunities.